[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100579670":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":18,"responsibleParty":33,"collaborators":7,"id":35,"slug":36,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":39,"acronym":7,"eligibilityCriteria":40,"healthyVolunteers":37,"sex":41,"minAge":42,"maxAge":7,"enrollmentInfo":43,"targetDuration":7,"studyType":46,"phases":7,"briefSummary":47,"conditions":48,"keywords":7,"overallStatus":20,"whyStopped":7,"lastUpdateSubmitDate":51,"lastUpdatePostDateStruct":52,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":60},{"fullName":5,"class":6},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Luciano G Potena, MD","PRINCIPAL_INVESTIGATOR",[13],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"Luciano Potena, MD","CONTACT","0512143725","scompenso.trapiantocuore@aosp.bo.it",[19],{"facility":5,"status":20,"city":21,"state":21,"zip":22,"country":23,"countryCode":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"RECRUITING","Bologna","40138","Italy","IT",{"type":26,"coordinates":27},"Point",[28,29],11.33875,44.49381,{"lat":29,"lon":28},[32],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},{"type":34,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100579670","pharmacological-and-mechanical-support-approaches-in-the-management-of-acute-heart-failure-in-the-regional-network-model-for-the-management-of-cardiogenic-shock-100579670",false,"NCT06827314","Pharmacological and Mechanical Support Approaches in the Management of Acute Heart Failure in the Regional Network Model for the Management of Cardiogenic Shock","Inclusion Criteria:\n\n* Adult patients (≥18 years old) admitted to a participating CICU with suspected CS of stage from C to E according to SCAI (Society of cardiovascular intervention)classification of cardiogenic shock.\n* Signed informed consent.\n\nExclusion Criteria:\n\n* CS following cardiac surgery (post-cardiotomy), ● Significant polytrauma or neurological injury.","ALL","18 Years",{"count":44,"type":45},500,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to understand and describe the epidemiology of cardiogenic shock in Emilia Romagna with a specific focus on outcome stratified by aetiologies, sex and age. The main outcomes are:\n\n* Incidence of cardiogenic shock (CS) over the total CICU admissions, CS-related in-hospital mortality and length of hospitalization, stratified by aetiologies, sex and age\n* Epidemiology of patients admitted with CS, regarding age, gender, etiology and modality of presentation (acute or acute on chronic), echocardiographic and haemodynamic data, treatment strategy with inotropes and\u002For short-term MCS, cardiac arrest.\n\nThis is an observational study without intervention. Patients will be treated according to current clinical practice, according to physician judgment and data sheets of each drug used according to clinical practice.",[49,50],"Cardiogenic Shock","Acute Coronary Event","2025-02-13",{"date":53,"type":54},"2025-02-14","ACTUAL",{"date":56,"type":54},"2022-12-06",{"date":58,"type":45},"2027-11",{"name":5,"class":6},1]